Pleural mesothelioma, is an aggressive form of lung cancer strongly linked to asbestos exposure, which has very limited treatment options and is associated with poor patient survival, with most having less than a year left to live once diagnosed.1 Eight leading UK cancer research centres are participating in a ground-breaking new study to evaluate a potential new treatment targeting cancer stem cells, and measure if the life expectancy of these patients could be prolonged.
No comments:
Post a Comment